中药透皮疗法治疗肺间质纤维化的可行性

肺间质纤维化是呼吸系统的高发病,其病变主要累及肺间质,肺间质内出现大量胶原蛋白沉积,导致气体弥散功能障碍。此病进展快,预后差,多合并呼吸衰竭死亡。既往治疗多采用西药糖皮质激素等,效果差,副作用大。根据肺与皮肤的密切关系,近些年逐渐兴起了中药透皮疗法治疗肺间质纤维化。主要通过电或热的方法使中药颗粒渗透入血液循环,达到抑制胶原蛋白合成的作用。此种方法价格低廉、操作简单、起效快、安全可靠、无毒副作用,发展前景广阔。

Feasibility of treating interstitial pulmonary fibrosis by TCM transdermal therapy

Interstitial pulmonary fibrosis is the high incidence of respiratory lesions involving the interstitial lung interstitial lung collagen deposition,leading to the gas diffusion dysfunction.progression of disease rapid and poor prognosis,and more complicated with respiratory failure and death.Previous treatment by western medicine glucocorticoid with side effects.According to the close relationship of the lung and skin,in recent years,the gradual rise of the TCM transdermal therapy for pulmonary interstitial fibrosis.Mainly by the methods of electricity or heat to penetrate into the blood circulation,inhibition of collagen synthesis in TCM granules.This method is inexpensive,simple operation,rapid onset,safe and reliable,non-toxic side effects and broad development prospects.